BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 2581393)

  • 21. [Human B-HCG and AFP as biological markers in germinal testicular tumors].
    Huertas Mora RA; Larrodera López L; Gómez Matobella I; Cortes Funes H
    Rev Esp Oncol; 1984; 31(2):321-30. PubMed ID: 6085865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of mediastinal teratoid tumors].
    Ito M; Miyake M; Mitsuoka A
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1361-70. PubMed ID: 2409924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-seminomatous germ cell tumors of the testis. Immunohistochemical localization and serum levels of human chorionic gonadotropin (HCG) and pregnancy-specific beta-1 glycoprotein (SP-1); value of SP-1 as a tumor marker.
    Suurmeijer AJ; De Bruijn HW; Oosterhuis JW; Sleyfer DT; Koops HS; Fleuren GJ
    Oncodev Biol Med; 1982; 3(5-6):409-22. PubMed ID: 6292873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin].
    Nishiyama K; Nishida K; Kusaka K; Morizumi H
    No Shinkei Geka; 1987 Dec; 15(12):1337-42. PubMed ID: 2452372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The "false positive" tumor marker in malignant testicular tumor].
    Bussar-Maatz R; Weissbach L; Dahlmann N; Mann K
    Urologe A; 1993 May; 32(3):177-82. PubMed ID: 8511831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor markers in testicular tumors].
    Jibiki K; Odagiri E; Demura R; Demura H; Yamaguchi Y
    Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ; Bosl GJ
    J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the management of testicular cancer.
    Ellis M; Sikora K
    Drugs Exp Clin Res; 1986; 12(1-3):219-31. PubMed ID: 2426072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.